Literature DB >> 11577124

Colonisation density and topographic localisation of Helicobacter pylori do not depend on the cagA status.

M Twisk1, J G Kusters, A G Balk, E J Kuipers, R J Loffeld.   

Abstract

AIMS: To explore the correlation between the cagA status of Helicobacter pylori and the density and topographic localisation of H pylori.
METHODS: Gastric antral biopsy specimens were taken from 716 consecutive patients, including 293 H pylori positive patients (124 men, 169 women; mean age, 52.6 years; range, 12-87). A serum sample was taken for determination of IgG anti-CagA antibodies (sensitivity of 94.4% and specificity of 92.5%). The density of H pylori was assessed semiquantitatively (grades I-IV) in biopsy specimens stained with the modified Giemsa stain. Topographic localisation was classified as follows: score A, H pylori closely attached to the mucosa; score B, H pylori attached to the mucosa and in the mucus; and score C, H pylori solely in the mucus.
RESULTS: CagA antibodies were present in 154 (52.5%) of the patients. There was no significant difference in colonisation density and cagA status: grade I, 23 (14%); grade II, 78 (50.6%); grade III, 42 (27.5%); and grade IV, 11 (7.2%) in the cagA(+) strains and 29 (21.2%), 57 (40.8%), 38 (27%), and 15 (11%), respectively, in the cagA(-) strains. There was no difference in topographic localisation between cagA(+) and cagA(-)H pylori. Mean anti-CagA titres were 0.84, 0.84, 0.89, and 0.73 in patients with grades I-IV bacterial density, respectively.
CONCLUSION: Antibody titres do not correlate with H pylori density and there is no difference in density between cagA(+) and cagA(-)H pylori strains. In addition there is no difference in topographic localisation between cagA(+) and cagA(-) H pylori strains.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11577124      PMCID: PMC1731292          DOI: 10.1136/jcp.54.10.771

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  Rapid staining of Campylobacter pyloridis.

Authors:  H V Potters; R J Loffeld; E Stobberingh; J P van Spreeuwel; J W Arends
Journal:  Histopathology       Date:  1987-11       Impact factor: 5.087

2.  The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases.

Authors:  J F Weel; R W van der Hulst; Y Gerrits; P Roorda; M Feller; J Dankert; G N Tytgat; A van der Ende
Journal:  J Infect Dis       Date:  1996-05       Impact factor: 5.226

3.  Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori.

Authors:  E D Segal; J Cha; J Lo; S Falkow; L S Tompkins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

4.  Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology.

Authors:  J C Atherton; K T Tham; R M Peek; T L Cover; M J Blaser
Journal:  J Infect Dis       Date:  1996-09       Impact factor: 5.226

5.  IgG antibody titer against Helicobacter pylori correlates with presence of cytotoxin associated gene A-positive H. pylori strains.

Authors:  R J Loffeld; B F Werdmuller; J G Kusters; E J Kuipers
Journal:  FEMS Immunol Med Microbiol       Date:  2000-06

6.  Diagnostic value of an immunoassay to detect anti Campylobacter pylori antibodies in non-ulcer dyspepsia.

Authors:  R J Loffeld; E Stobberingh; J A Flendrig; J P van Spreeuwel; J W Arends
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

7.  Omeprazole may exert both a bacteriostatic and a bacteriocidal effect on the growth of Helicobacter pylori (NCTC 11637) in vitro by inhibiting bacterial urease activity.

Authors:  F Mirshahi; G Fowler; A Patel; G Shaw
Journal:  J Clin Pathol       Date:  1998-03       Impact factor: 3.411

8.  Value of serology (ELISA and immunoblotting) for the diagnosis of Campylobacter pylori infection.

Authors:  A S Peña; H P Endtz; G J Offerhaus; A Hoogenboom-Verdegaal; W van Duijn; N de Vargas; G den Hartog; J Kreuning; J van der Reyden; R P Mouton
Journal:  Digestion       Date:  1989       Impact factor: 3.216

9.  Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach.

Authors:  M J Blaser; G I Perez-Perez; H Kleanthous; T L Cover; R M Peek; P H Chyou; G N Stemmermann; A Nomura
Journal:  Cancer Res       Date:  1995-05-15       Impact factor: 12.701

10.  Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells.

Authors:  M Asahi; T Azuma; S Ito; Y Ito; H Suto; Y Nagai; M Tsubokawa; Y Tohyama; S Maeda; M Omata; T Suzuki; C Sasakawa
Journal:  J Exp Med       Date:  2000-02-21       Impact factor: 14.307

View more
  2 in total

1.  Cervical cancer.

Authors:  P J van Diest; H Holzel
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

2.  Increased H. pylori stool shedding and EPIYA-D cagA alleles are associated with gastric cancer in an East Asian hospital.

Authors:  Sarah Talarico; Christina K Leverich; Bing Wei; Jie Ma; XinGuang Cao; YongJun Guo; GuangSen Han; Lena Yao; Steve Self; Yuzhou Zhao; Nina R Salama
Journal:  PLoS One       Date:  2018-09-12       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.